According to Tarsus Pharmaceuticals's latest financial reports the company's current revenue (TTM) is £63.52 M. In 2023 the company made a revenue of £13.69 M a decrease over the revenue in the year 2022 that were of £21.33 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.